This inventor holds 2 USPTO granted patents. Top assignee: Oncogen. Active years: 1993-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1996
Title: Kim R Folger-Bruce: Innovator in Chimeric Antibody Production
Introduction
Kim R Folger-Bruce is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the production of chimeric antibodies. With a total of 2 patents, his work has advanced the understanding and application of recombinant DNA technology.
Latest Patents
Kim R Folger-Bruce's latest patents focus on the production of chimeric antibodies through homologous recombination. This innovative process utilizes novel recombinant DNA vectors to facilitate targeted gene modification in antibody-producing cells. The recombinant DNA constructs developed by Folger-Bruce enable the transfection of these cells, leading to the efficient production of chimeric antibody molecules.
Career Highlights
Throughout his career, Kim has been associated with Oncogen, where he has applied his expertise in biotechnology. His work has been instrumental in developing methods that enhance the production of therapeutic antibodies, which are crucial in treating various diseases.
Collaborations
Kim R Folger-Bruce has collaborated with notable colleagues, including H Perry Fell and Susan M Yarnold. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of biotechnological research.
Conclusion
In summary, Kim R Folger-Bruce is a distinguished inventor whose work in chimeric antibody production has made a significant impact in biotechnology. His innovative approaches and collaborations continue to drive advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile